ClinicalTrialsFinder
RecruitingNCT07228611

Assesment and Comparison of Osteoporosis Risk Factors After Stroke

Comparison of Osteoporosis Risk in the Subacute and Chronic Periods Following Stroke and Evaluation of Factors Increasing Osteoporosis

Sponsor

Ankara Etlik City Hospital

Enrollment

84 participants

Start Date

Dec 5, 2025

Study Type

OBSERVATIONAL

Conditions

Stroke Osteoporosis

Summary

The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.

Eligibility

Min Age: 55 YearsMax Age: 85 Years

Inclusion Criteria3

  • Followed by ischemic or hemorrhagic stroke
  • Between 1 week and 6 months or >1 year has passed since the date of the event
  • Being between 55 and 85 years of age

Exclusion Criteria10

  • The patient has additional neurological conditions besides stroke
  • The patient has a psychiatric condition
  • History of recurrent stroke
  • BMD scan performed within the last year for stroke patients
  • Having received osteoporosis treatment before or after the stroke
  • The patient having a fragility fracture before the stroke
  • The patient having a hip fracture or hip prosthesis
  • The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture)
  • The patient has an additional disease or medication use that could cause secondary osteoporosis
  • The patient's stroke did not cause physical function loss

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBone Mineral Density

Patients who have had a stroke and are at risk of fracture, and for whom routine assessment requires Bone Mineral Density (BMD) testing, will be included in the study. In addition, patients who have already undergone BMD testing for osteoporosis screening and who present to the outpatient clinic, with similar age and comorbidities, will be screened from the system, and 28 non-stroke patients who agree to participate will be included in the study.

Locations(1)

Ankara Etlik City Hospital

Ankara, Yenimahalle, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07228611